7XB
vs
D
DAX Index
7XB
Over the past 12 months, 7XB has significantly outperformed DAX Index, delivering a return of +89% compared to the DAX Index's +9% growth.
Stocks Performance
7XB vs DAX Index
Performance Gap
7XB vs DAX Index
Performance By Year
7XB vs DAX Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Xbrane Biopharma AB
Glance View
Xbrane Biopharma AB is a biopharmaceutical company, which engages in the development and manufacture of biosimilars. The company is headquartered in Solna, Stockholm. The company went IPO on 2016-02-03. The company develops biogenerics for injectable slow release drugs and high-yield protein expression technology for the development of biosimilars. The firm's main products are Sperotide, a generic on the originator drug marketed under the trademarks Decapeptyl, Trelstar and Pamorelin, as well as Xlucane, a biosimilar on the originator drug sold under the trademark Lucentis.